Page last updated: 2024-12-05

thiamine monophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Thiamine monophosphate (TMP) is a phosphorylated derivative of thiamine (vitamin B1). It is synthesized in the body from thiamine and ATP. TMP is an important cofactor for several enzymes involved in carbohydrate metabolism, including pyruvate dehydrogenase and α-ketoglutarate dehydrogenase. It is involved in the synthesis of neurotransmitters and the production of energy. TMP is crucial for normal nerve function, muscle function, and brain development. Studies have shown that TMP may be beneficial in treating conditions such as Alzheimer's disease, Parkinson's disease, and diabetic neuropathy. TMP has been shown to have neuroprotective effects, reducing oxidative stress and inflammation in the brain. It has also been studied for its potential role in improving cognitive function and memory.'

Thiamine Monophosphate: Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thiamine(1+) monophosphate chloride : An organic chloride salt of thiamine(1+) monophosphate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10761
CHEMBL ID2106811
CHEBI ID18338
SCHEMBL ID94443
MeSH IDM0021321

Synonyms (57)

Synonym
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium chloride
monophosphothiaminum
monophosphothiamine
CHEBI:18338 ,
thiamin dihydrogenphosphatchlorid
vitamin b1 phosphate
thiamine(1+) monophosphate chloride
monofosfotiamina
thiamine monophosphate chloride
monophosphoric ester of thiamine
vitamin b1 monophosphate
thiamine monophosphate
532-40-1
NCGC00164500-01
phosphothiaminum
D08581
monophosphothiamine (inn)
dtxsid6046397 ,
cas-532-40-1
tox21_112138
dtxcid4026397
phosbitamin
phosphothiamin
vitamin b1 monophosphate chloride
superneurina
fosbione
CHEMBL2106811
tmp (thiamine ester)
sineurina
phosphothiamine
novobeta
novaneurina
extraneurina
neurifosforil
monophosphothiamine [inn:dcf]
unii-p712t71q3t
tiamina monofosfato
monofosfotiamina [inn-spanish]
aneurin-monophosphorsaeureesterchlorid
monophosphothiaminum [inn-latin]
einecs 208-536-9
p712t71q3t ,
tiamina monofosfato [dcit]
thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)-, chloride
monophosphothiamine [inn]
thiamine phosphoric acid ester chloride
monophosphothiamine [who-dd]
thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)-, chloride (1:1)
thiamine monophosphate [mi]
SCHEMBL94443
AKOS024375439
SR-01000883748-1
sr-01000883748
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl dihydrogen phosphate;chloride
Q7783877
thiaminemonophosphate
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyldihydrogenphosphate;chloride

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic parameters AUC0-24h, Cmax and tmax of the benfotiamin group in whole blood and plasma exceeded significantly those in the TN group."( Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
Bitsch, R; Frank, T; Maiwald, J; Stein, G, 1999
)
0.3

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic chloride salt
vitamin B1Any member of the group of 1,3-thiazolium cations that exhibit biological activity against vitamin B1 deficiency in animals. Symptoms of vitamin B1 deficiency include constipation, loss of apetite, fatigue, nausea, delirium, blurry vision and muscle weakness. Severe vitamin B1 deficiency can also lead to a disease known as beriberi. Vitamin B1 consists of the vitamer thiamin and its acid, aldehyde and phosphorylated derivatives (and their corresponding ionized, salt and hydrate forms).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency5.35380.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki7,377.50000.00121.25638.9000AID1147919; AID1147920; AID1147921; AID1147922
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1147922Noncompetitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 8.25 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID1147919Competitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 7 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID1147920Noncompetitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 7 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID1147921Competitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 8.25 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (149)

TimeframeStudies, This Drug (%)All Drugs %
pre-199064 (42.95)18.7374
1990's39 (26.17)18.2507
2000's28 (18.79)29.6817
2010's11 (7.38)24.3611
2020's7 (4.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.89 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index37.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.27%)5.53%
Reviews6 (3.80%)6.00%
Case Studies2 (1.27%)4.05%
Observational0 (0.00%)0.25%
Other148 (93.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]